To clarify the determinants of prognostic signinificance in epithelial tumors of the urinary bladder, 228 patients, who were initially treated at Department of Urology, Nagoya University Hospital in the last ten years from 1973 to 1982, were analyzed.
The overall 5-year actuarial and relative survival rates were 63.7% and 73.3%, respectively. For patients treated by TUR, TUC, transvesical resection, partial cystectomy and total cystectomy, the 5-year actuarial survival rates (5Y-ASR) were 84.8%, 100%, 79.0%, 39.2% and 39.4%, correspondingly.
Determinants of favorable survivorship were searched in such clinico-pathological factors as sex, age, symptoms, interval between onset of initial symptoms and hospital visit, and tumor characteristics: location, number, size, macroscopic appearance, histological type, grade, stage and growth pattern. The following major findings emerged from this particular analysis.
1) The relative survival outcome was slightly more unfavorable in females (56.7%) than in males (77.5%), and in those aged over 70 years (63.0%) than in those aged much younger (Age≤49: 77.5%, 50-59: 74.5%, 60-69: 75.7%), but significantly so in those with irritative bladder symptoms (45.9%) than in those without (85.2%).
2) Patients with tumors in the region adjacent to the ureteral orifices demonstrated a more favorable survivorship than those with tumors in the remaining regions (5Y-ASR for the region adjacent to the ureteral orifices: 78.5%, lateral wall: 57.6%, posterior wall: 48.5%, trigone: 58.3%, dome: 64.8%, bladder neck: 54.7%, whole wall: 53.0%).
3) Patients with tumors larger than 3 cm in diameter succumbed much earlier than those with less large tumors (5Y-ASR for≤1cm: 88.3%, 1.1-3cm: 65.8%, 3.1-5cm: 28.8%, >5cm: 32.0%).
4) Patients with papillary-pedunculated tumor experienced the most favorable survival outcome (5Y-ASR: 95.3%), followed by those with papillary-sessile tumor (68.4%) and nonpapillary-sessile tumor (43.7%).
5) The 5-year actuarial survival rates were 84.3%, 71.9%, 50.6%, 29.3%, 26.8% and 7.7% in the patients with histological stage of pTa, pT1, pT2, pT3a, pT3b and pT4, respectively.
6) Among patients with transitional cell carcinoma, the 5-year actuarial survival rate was 94.4% for grade 1, 75.9% for grade 2, and 42.3% for grade 3. In those with non-transitional cell carcinoma the rate was 45.0%.
7) The 5-year actuarial survival rates were 86.5%, 62.0% and 35.0% in papillary non-invasive, papillary invasive and non-papillary invasive type, respectively.
8) Survival outcome was not significantly associated with the number of tumors and the interval between onset of initial symptoms and hospital visit.
In short, the determinants of prognostic significance in epithelial tumors of the urinary bladder were concluded to be sex, age, irritative bladder symptoms and such tumor characteristics as location, size, macroscopic appearance, histological type, grade, stage and growth pattern.
View full abstract